# Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment

> **NCT01052701** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 26 (actual)

## Conditions studied

- Hepatitis C
- HIV

## Interventions

- **DRUG:** Ribavirin
- **DRUG:** Ribavirin plus Abacavir (ABC)

## Key facts

- **NCT ID:** NCT01052701
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-09
- **Final completion:** 2012-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052701, "Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01052701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*